SSRI or SNRI antidepressant use may increase risk of type 2 diabetes in youthsStudy shows risk intensifies with increasing duration of use, cumulative dose and average daily dose Recommendations for promoting antipsychotic safety in patients with schizophrenia Latuda now approved for use in schizophrenia in 15- to 17-year-olds Manufacturer has also filed for approval of lurasidone to treat bipolar depression in youth Study points to link between antidepressant use in pregnancy and autism in children But absolute risk small, so results should not be considered alarming, say researchers Treating depression that is unresponsive to an antidepressant course Study examines effect of antidepressant switching vs augmentation therapy Pharmacist interventions enhance adherence to antidepressant meds But little evidence of positive effects on depression symptoms Canada becomes 30th country to have national dementia strategy Managing post-traumatic stress disorder Review outlines clinical features, patient assessment, treatment and prevention Canadian researchers discover brain inflammation in people with OCD Finding could lead to development of new treatments for the condition Comorbid disorders may affect methadone maintenance treatment Comorbid cocaine or tranquilizer use disorder may increase rates of continuing opioid use First Previous 23 24 25 26 27 Next Last